Concert Pharmaceuticals Inc. sell Lokrim
Start price
17.10.21
/
20%
€2.44
Target price
17.10.22
-
Performance (%)
121.23%
End price
28.05.22
€5.40
Summary
This prediction ended on 28.05.22 with a price of €5.40. The SELL prediction by Lokrim for Concert Pharmaceuticals Inc. was trending in the completely wrong direction and closed with a performance of 121.23%. Lokrim has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Concert Pharmaceuticals Inc. | - | - | - |
| iShares Core DAX® | 1.804% | -0.748% | 13.168% |
| iShares Nasdaq 100 | -0.182% | -3.412% | 39.976% |
| iShares Nikkei 225® | 0.413% | -7.381% | 18.776% |
| iShares S&P 500 | 0.664% | -1.941% | 28.141% |
According to Lokrim what are the pros and cons of Concert Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Lokrim for this prediction
In the thread Concert Pharmaceuticals Inc. diskutieren
Sell Concert Pharmaceuticals Inc.
In the thread Trading Concert Pharmaceuticals Inc.
Stopped prediction by Lokrim for Concert Pharmaceuticals Inc.
Concert Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.40
28.05.22
28.05.22
-
28.05.23
28.05.23
46.05%
24.04.23
24.04.23
Could be worthwhile Investment >10% per year
